Research ArticleNeurology
Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
Alex Whittington, David J. Sharp and Roger N. Gunn; for the Alzheimer’s Disease Neuroimaging Initiative
Journal of Nuclear Medicine May 2018, 59 (5) 822-827; DOI: https://doi.org/10.2967/jnumed.117.194720
Alex Whittington
1Division of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
David J. Sharp
1Division of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
Roger N. Gunn
1Division of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom
2Imanova Ltd., London, United Kingdom; and
3Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 5
May 1, 2018
Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
Alex Whittington, David J. Sharp, Roger N. Gunn
Journal of Nuclear Medicine May 2018, 59 (5) 822-827; DOI: 10.2967/jnumed.117.194720
Jump to section
Related Articles
Cited By...
- Passive Immunotherapies Targeting Amyloid-{beta} in Alzheimers Disease: A Quantitative Systems Pharmacology Perspective
- Personalised Regional Modelling Predicts Tau Progression in the Human Brain
- Manipulation of neuronal activity in the entorhinal-hippocampal circuit affects intraneuronal amyloid-{beta} levels
- Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts
- TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
- Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
- Amplification, not spreading limits rate of tau aggregate accumulation in Alzheimers disease
- Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults
- Amyloid duration is associated with preclinical cognitive decline and tau PET
- Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging